Both in Pharmaceuticals
Palvella Therapeutics vs Zymeworks
Over the past year PVLA returned +103.7% and ZYME returned +56.6%; their daily moves had a correlation of 0.24.
PVLA +103.7% ZYME +56.6%Growth of $1, one year, split-adjusted
| Metric | PVLA | ZYME |
|---|---|---|
| Price | $143.45 | $28.92 |
| Market cap | $2.07B | $2.08B |
| Today | +7.93% | +0.24% |
| 1 month | +3.2% | +6.3% |
| 6 months | +17.2% | +3.9% |
| Year to date | +37.0% | +9.8% |
| 1 year | +103.7% | +56.6% |
| Revenue growth (YoY) | — | −90.6% |
| Gross margin | — | 100.0% |
| Net margin | — | −980.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 56.0× |
| Net cash | $250.6M | $270.7M |
| Dividend yield | — | — |
| Volatility (60d) | 43.9% | 47.0% |
| Short % of float | 21.7% | 13.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).